{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031303","form_type":"8-K","ticker":"RNXT","cik":"0001574094","company_name":"RenovoRx, Inc.","filed_at":"2026-06-30T20:55:23+00:00","discovered_at":"2026-06-30T20:56:00.264224+00:00","generated_at":"2026-06-30T20:56:04.174198+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"RenovoRx stockholders elect directors, approve equity plan amendment, ratify auditor at 2026 annual meeting","bullets":["All six director nominees elected with 12.9M+ votes for each; broker non-votes of 9.6M.","Amendment to 2021 Omnibus Equity Incentive Plan approved: 9.7M for, 3.6M against; adds 2,000,000 shares (4.4% of outstanding).","Ratification of Frank, Rimerman + Co. LLP as auditor for FY 2026: 21.9M for, 477k against.","Approximately 22.8M shares (50.6% of 45.1M outstanding) present or represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031303","json":"https://secwatch.observer/filing/0001493152-26-031303.json","markdown":"https://secwatch.observer/filing/0001493152-26-031303.md","text":"https://secwatch.observer/filing/0001493152-26-031303.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574094/000149315226031303/0001493152-26-031303-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574094/000149315226031303/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T20:56:04.174198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}